Skip Nav Destination
Letter|
March 16, 2021
Incidence of Skin Hyperpigmentation in Black Patients Receiving Treatment with Immunomodulatory Drugs
Clinical Trials & Observations
Charles J. Milrod
,
Charles J. Milrod
Boston University Medical Center, Boston, Massachusetts, United States
Search for other works by this author on:
Frances R Blevins
,
Frances R Blevins
Boston University Medical Center, Boston, Massachusetts, United States
Search for other works by this author on:
David Hughes
,
David Hughes
Boston Medical Center, Boston, Massachusetts, United States
Search for other works by this author on:
Adam Lerner
,
Adam Lerner
Boston University School of Medicine, Boston, Massachusetts, United States
Search for other works by this author on:
Shayna Sarosiek
,
Shayna Sarosiek
Boston University Medical Center, Boston, Massachusetts, United States
Search for other works by this author on:
Vaishali Sanchorawala
,
Vaishali Sanchorawala
Boston University Medical Center
Search for other works by this author on:
J. Mark Sloan
Boston University, Boston, Massachusetts, United States
* Corresponding Author; email: mark.sloan@bmc.org
Search for other works by this author on:
Blood blood.2021010853.
Article history
Submitted:
January 15, 2021
Revision Received:
February 16, 2021
Accepted:
February 16, 2021
Citation
Charles J. Milrod, Frances R Blevins, David Hughes, Adam Lerner, Shayna Sarosiek, Vaishali Sanchorawala, J. Mark Sloan; Incidence of Skin Hyperpigmentation in Black Patients Receiving Treatment with Immunomodulatory Drugs. Blood 2021; blood.2021010853. doi: https://doi.org/10.1182/blood.2021010853
Download citation file:
Advertisement
0
Citations
Cited By
Email alerts
Advertisement